NO164020C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.

Info

Publication number
NO164020C
NO164020C NO861474A NO861474A NO164020C NO 164020 C NO164020 C NO 164020C NO 861474 A NO861474 A NO 861474A NO 861474 A NO861474 A NO 861474A NO 164020 C NO164020 C NO 164020C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogy procedure
phenetanolamine
derivatives
Prior art date
Application number
NO861474A
Other languages
English (en)
Norwegian (no)
Other versions
NO861474L (no
NO164020B (no
Inventor
Leo Alig
Marcel Mueller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO861474L publication Critical patent/NO861474L/no
Publication of NO164020B publication Critical patent/NO164020B/no
Publication of NO164020C publication Critical patent/NO164020C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO861474A 1985-04-16 1986-04-15 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater. NO164020C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH160785 1985-04-16
CH59986 1986-02-14

Publications (3)

Publication Number Publication Date
NO861474L NO861474L (no) 1986-10-17
NO164020B NO164020B (no) 1990-05-14
NO164020C true NO164020C (no) 1990-08-22

Family

ID=25685078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861474A NO164020C (no) 1985-04-16 1986-04-15 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.

Country Status (16)

Country Link
US (1) US5017619A (sv)
EP (1) EP0198412B1 (sv)
AR (1) AR242019A1 (sv)
AT (1) ATE41655T1 (sv)
AU (1) AU592557B2 (sv)
DE (1) DE3662521D1 (sv)
DK (1) DK163486A (sv)
ES (2) ES8802132A1 (sv)
FI (1) FI84170C (sv)
HU (1) HU200161B (sv)
IL (1) IL78475A0 (sv)
MC (1) MC1744A1 (sv)
NO (1) NO164020C (sv)
NZ (1) NZ215753A (sv)
PH (1) PH22941A (sv)
PT (1) PT82399B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA868891B (en) * 1985-11-27 1988-07-27 Lilly Co Eli Use of phenethanol amines to improve fat content of sow's milk
JPH0761992B2 (ja) * 1987-02-06 1995-07-05 武田薬品工業株式会社 置換アミン誘導体
CA2010638A1 (en) * 1989-03-07 1990-09-07 Leo Alig Bisphenethanolamines
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
GB9308178D0 (en) * 1993-04-21 1993-06-02 Smithkline Beecham Plc Novel compounds
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US6043253A (en) * 1998-03-03 2000-03-28 Merck & Co., Inc. Fused piperidine substituted arylsulfonamides as β3-agonists
GB0324654D0 (en) * 2003-10-22 2003-11-26 Glaxo Group Ltd Medicinal compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL108640C (sv) * 1958-05-07
NL302260A (sv) * 1963-01-24 1900-01-01
GB1109924A (en) * 1965-11-29 1968-04-18 Roche Products Ltd Novel substituted diphenylalkyl amines and a process for the manufacture thereof
US3553266A (en) * 1968-08-08 1971-01-05 American Home Prod Diaralkylamine derivatives
US3577462A (en) * 1968-08-08 1971-05-04 American Home Prod N-arylalkyl-beta-hydroxy-beta-phenyl-ethylamines and the salts thereof
US3706764A (en) * 1969-04-16 1972-12-19 Yoshitomi Pharmaceutical Phenethylaminomethyl-chromanones and- thiochromanones
DE2143204C3 (de) * 1971-08-28 1979-09-27 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt N-Fluoralkyl-phenylisopropylamin-Derivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
EP0021636B1 (en) * 1979-06-16 1982-12-01 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0118489A1 (en) * 1982-08-27 1984-09-19 Beecham Group Plc Secondary arylethanolamines
GB8415377D0 (en) * 1984-06-15 1984-07-18 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
US5017619A (en) 1991-05-21
ES553974A0 (es) 1988-04-16
DK163486A (da) 1986-10-17
PT82399A (en) 1986-05-01
FI84170C (sv) 1991-10-25
IL78475A0 (en) 1986-08-31
DK163486D0 (da) 1986-04-10
MC1744A1 (fr) 1987-02-26
FI84170B (fi) 1991-07-15
FI861590A0 (fi) 1986-04-15
NZ215753A (en) 1989-10-27
NO861474L (no) 1986-10-17
ES8802132A1 (es) 1988-04-16
EP0198412B1 (de) 1989-03-22
AU5579186A (en) 1986-10-23
PT82399B (pt) 1988-08-17
AU592557B2 (en) 1990-01-18
ATE41655T1 (de) 1989-04-15
PH22941A (en) 1989-02-03
HUT42054A (en) 1987-06-29
DE3662521D1 (de) 1989-04-27
EP0198412A1 (de) 1986-10-22
AR242019A1 (es) 1993-02-26
ES8801894A1 (es) 1988-03-01
FI861590A (fi) 1986-10-17
ES557291A0 (es) 1988-03-01
HU200161B (en) 1990-04-28
NO164020B (no) 1990-05-14

Similar Documents

Publication Publication Date Title
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO170884C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO855356L (no) Fremgangsmaate ved fremstilling av cefem-derivater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO864782D0 (no) Fremgangsmaate ved fremstilling av kinolon-derivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO168706C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO167284C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksazol- og isoksazolderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO169962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.